Fenfluramin

Fenfluramin
(IUPAC) ime
	(RS)-N-etil- 1-[3-(trifluorometil)fenil]propan- 2-amin
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	458-24-2
ATC kod	A08AA02
PubChem	3337
DrugBank	DB00574
ChemSpider	3220
UNII	2DS058H2CF
KEGG	D07945
ChEBI	CHEBI:5000
ChEMBL	CHEMBL87493
Hemijski podaci
Formula	C12H16F3N
Mol. masa	231,26 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3 ; Key: DBGIVFWFUFKIQN-UHFFFAOYSA-N
Farmakokinetički podaci
Poluvreme eliminacije	20 sata
Farmakoinformacioni podaci
Trudnoća	C(US)
Pravni status	Plan IV
Način primene	Oralno

Fenfluramin (3-trifluorometil-N-etilamfetamin, Pondimin, Ponderaks, Adifaks) je lek koji je bio deo Fen-Phen leka protiv gojaznosti (drugi sastojak je bio fentermin). Fenfluramin je uveden na američko tržište 1973. On je racemska smeša dva enantiomera, dekstrofenfluramina i levofenfluramina. On povišava nivo neurotransmitera serotonina, hemikalije koja reguliše raspoloženje, apetit i druge funkcije. Fenfluramin uzrokuje otpuštanje serotonina putem ometanja vezikularnog skladištenja neurotransmitera, i preusmeravanja dejstva serotoninskog transportera.^[6] Rezultat toga je osećanje sitosti i gubitak apetita.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Nestler, E. J. (2001). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. McGraw-Hill.

Literatura

Welch, J. T.; Lim, D. S. (2007). „The Synthesis and Biological Activity of Pentafluorosulfanyl Analogs of Fluoxetine, Fenfluramine, and Norfenfluramine”. Bioorganic & Medicinal Chemistry 15 (21): 6659–6666. DOI:10.1016/j.bmc.2007.08.012. PMID 17765553.

Povezano

Vanjske veze

RxList.com - Fenfluramine Arhivirano 1996-11-14 na Wayback Machine-u
Inchem.org - Fenfluramine

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Nestler, E. J. (2001). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. McGraw-Hill.

[1]

[2]

[3]

[4]

[5]

[6]